Cohen & Steers(CNS)

Search documents
Cohen & Steers Real Estate Securities Fund Receives LSEG Lipper Performance Award
Prnewswire· 2025-03-24 13:00
NEW YORK, March 24, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today that the Cohen & Steers Real Estate Securities Fund (CSZIX) has received a 2025 LSEG Lipper Fund Award for its strong risk-adjusted performance over the 10-year period, ended November 30, 2024. This is the tenth consecutive year Lipper has recognized the Fund. For 2025, the Real Estate category for the 10-year period included 136 share classes. Jason Yablon, Head of Listed Real Estate, said:"We are honored to be recogn ...
Xenon to Present at Stifel 2025 Virtual CNS Forum
GlobeNewswire News Room· 2025-03-12 20:01
VANCOUVER, British Columbia and BOSTON, March 12, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced that the company will present at the Stifel 2025 Virtual CNS Forum taking place from March 18-19, 2025. Fireside Chat Presentation Details: Date:Wednesday, March 19, 2025 Time:12:00-12:25 PM Eastern Time Webcast:Register here ...
Neurocrine Biosciences to Present at the Stifel 2025 Virtual CNS Forum
Prnewswire· 2025-03-11 20:01
Core Insights - Neurocrine Biosciences, Inc. will participate in the Stifel 2025 Virtual CNS Forum on March 18, 2025, at 1:30 p.m. Eastern Time, with presentations from CEO Kyle Gano and CMO Eiry Roberts [1] - The live webcast of the event will be available on the company's website, with a replay accessible approximately one hour after the event and archived for about one month [2] Company Overview - Neurocrine Biosciences is a leading biopharmaceutical company focused on neuroscience, dedicated to developing treatments for neurological, neuroendocrine, and neuropsychiatric disorders [3] - The company has a diverse portfolio that includes FDA-approved treatments for conditions such as tardive dyskinesia, Huntington's disease-related chorea, classic congenital adrenal hyperplasia, endometriosis, and uterine fibroids, along with a robust pipeline of compounds in mid- to late-phase clinical development [3] - With three decades of experience, Neurocrine applies insights into neuroscience to address complex conditions and aims to relieve suffering for patients with significant unmet needs [3]
Cohen & Steers Announces the Retirement of Daniel P. Charles, Head of Global Distribution
Prnewswire· 2025-03-10 20:35
Core Viewpoint - Cohen & Steers, Inc. announces the retirement of Daniel P. Charles, Executive Vice President and Head of Global Distribution, after 37 years in sales leadership roles, with a search for his successor already underway [1][2]. Company Overview - Cohen & Steers is a leading global investment manager specializing in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equities, commodities, and multi-strategy solutions [3]. - The firm was founded in 1986 and is headquartered in New York City, with additional offices in London, Dublin, Hong Kong, Tokyo, and Singapore [3]. Leadership Transition - Daniel P. Charles has been instrumental in realigning U.S. distribution efforts to better meet client needs for real assets and alternative investment solutions, as well as expanding distribution across EMEA and APAC [2]. - Joseph Harvey, CEO, acknowledged Mr. Charles' contributions in enhancing distribution capabilities and building global sales teams, emphasizing a relationship culture and expanded marketing efforts [3].
Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for February 2025
Prnewswire· 2025-03-10 20:24
NEW YORK, March 10, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $88.6 billion as of February 28, 2025, an increase of $2.1 billion from assets under management of $86.4 billion at January 31, 2025. The increase was due to market appreciation of $2.3 billion, partially offset by distributions of $151 million and net outflows of $16 million. Assets Under Management (unaudited) ($ in millions) AUM Net Market AUM By investment ...
Cohen & Steers Launches SICAV Short Duration Preferred Income Fund
Prnewswire· 2025-03-03 09:00
Core Viewpoint - Cohen & Steers, Inc. has launched the Cohen & Steers SICAV Short Duration Preferred Income Fund, marking its second fund focused on the preferred securities market for UCITS investors, following the launch of the Cohen & Steers SICAV Preferred Income Fund in 2017 [1][4]. Company Overview - Cohen & Steers is a leading global investment manager specializing in real assets and alternative income, managing $18.3 billion in preferred securities since 2003 [4][7]. - The firm is headquartered in New York City and has offices in multiple global locations including London, Dublin, Hong Kong, Tokyo, and Singapore [7]. Fund Details - The new fund aims to provide high current income and capital preservation, focusing on investment-grade, institutional preferreds with a target duration of less than three years [3]. - The fund is managed by Elaine Zaharis-Nikas, along with Portfolio Managers Jerry Dorost and Robert Kastoff [3]. Market Insights - The preferred securities market is valued at $1.2 trillion, with significant opportunities driven by attractive market fundamentals and an increase in new issuances from institutional and non-financial companies [2][3]. - Preferred securities offer high yields, stable income, portfolio diversification, and low correlation to the broader fixed income market [2].
Cohen & Steers(CNS) - 2024 Q4 - Annual Report
2025-02-21 14:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the period from to Commission file number 001-32236 COHEN & STEERS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of Delaware 14-1904657 (I.R.S. Em ...
Cohen & Steers, Inc. Declares Quarterly Dividend
Prnewswire· 2025-02-20 21:23
Core Viewpoint - Cohen & Steers, Inc. has declared a cash dividend of $0.62 per share for Q1 2025, marking a 5.1% increase from the previous quarter's dividend of $0.59 per share [1]. Company Overview - Cohen & Steers is a prominent global investment manager that specializes in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equities, and commodities [2]. - The company was founded in 1986 and is headquartered in New York City, with additional offices located in London, Dublin, Hong Kong, Tokyo, and Singapore [2].
Trumpflation Positions Cohen & Steers Poorly Due To Real Estate And Preferred Focus
Seeking Alpha· 2025-02-19 22:50
Group 1 - The Value Lab focuses on long-only value investment ideas, aiming for a portfolio yield of about 4% and has performed well over the last 5 years by engaging in international markets [1][2] - Cohen & Steers (NYSE: CNS) experienced declines in assets under management (AUM) towards the end of the year due to depreciation of the assets in which AUM was invested [2] - The Valkyrie Trading Society consists of analysts sharing high conviction and obscure developed market ideas that are expected to generate non-correlated and outsized returns in the current economic environment [3] Group 2 - The Value Lab offers members real-time updates, 24/7 chat support, regular global market news reports, feedback on stock ideas, new trades monthly, quarterly earnings write-ups, and daily macro opinions [2]
LG CNS Joins SAP Regional Strategic Services Partner Initiative in Asia Pacific
Prnewswire· 2025-02-14 12:00
Core Insights - LG CNS has joined SAP's Regional Strategic Services Partner (RSSP) initiative to enhance its capabilities and reach in the APAC region [1][3] - The RSSP initiative aims to support partners in delivering industry-aligned solutions and joint go-to-market strategies [1][3] - LG CNS is the first Korean company and the fourth partner in the APAC region to join this initiative, aiming to expand its cloud ERP business [4] Company Developments - LG CNS plans to leverage its expertise in AI, cloud, and big data to drive next-generation ERP and SAP S/4HANA migration [5] - The company offers proprietary solutions like 'PerfecTwin ERP Edition' for error detection during SAP S/4HANA migration and 'SINGLEX,' a SaaS platform for integrated management functions [6][8] - The partnership with SAP is expected to enhance client value and drive business innovation in the Asia-Pacific region [7][8] Strategic Goals - LG CNS aims to scale its SAP practice quickly across the APAC region and collaborate closely with SAP for joint customer success [3][4] - The initiative requires partners to meet specific criteria, including geographical presence and vertical industry competencies [7]